Robert Hollingsworth has been appointed as the Chief Scientific Officer of Protillion Biosciences
PR Newswire —
A highly experienced leader in drug development, possessing over three decades of professional expertise, has been appointed to further the development of Protillion's advanced antibody discovery platform and its product pipeline. CARLSBAD, Calif., March 24, 2026 /PRNewswire/ --...